C07C 55/08
Malonic acid
C07C55/08 (Malonic acid) appears on 72 US grants and 90 published applications in this corpus.
Search patents in C07C- Granted patents
- 72
- Published applications
- 90
- Assignees
- 78
- Inventors
- 312
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 4 |
| 2010 | 0 | 2 |
| 2011 | 2 | 4 |
| 2012 | 3 | 5 |
| 2013 | 3 | 4 |
| 2014 | 3 | 5 |
| 2015 | 4 | 8 |
| 2016 | 8 | 9 |
| 2017 | 11 | 8 |
| 2018 | 4 | 5 |
| 2019 | 2 | 4 |
| 2020 | 5 | 1 |
| 2021 | 2 | 6 |
| 2022 | 5 | 3 |
| 2023 | 0 | 5 |
| 2024 | 3 | 4 |
| 2025 | 3 | 8 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Pharmaceutically acceptable salts of sepiapterin26 May 2026US 12,637,465 B2PTC Therapeutics MP, Inc.
- Salts and crystal forms of omecamtiv mecarbil28 Apr 2026US 12,612,366 B2Amgen Inc.
- Salts of (2R, 6R)-hydroxynorketamine, their crystal forms, and methods of making the same17 Feb 2026US 12,552,737 B2The United States Government as represented by the Department of Veterans Affairs
- Benzodiazepine compound, preparation method therefor, and use thereof in medicine18 Nov 2025US 12,473,291 B2West China Hospital, Sichuan University
- Psilocybin analogs, salts, compositions, and methods of use27 Aug 2026US 2026/0250246 A1Cybin IRL Limited
- Solid forms of macrocyclic compounds and uses thereof2 Jul 2026US 2026/0184727 A1Amgen Inc.
- Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereof2 Apr 2026US 2026/0092037 A1Praxis Precision Medicines, Inc.
- C4-substituted tryptamine derivatives and methods of using20 Nov 2025US 2025/0352512 A2Enveric Biosciences Canada Inc.
- Salts of c4-carboxylic acid- and c4-carbonothioate-substituted tryptamine derivatives and methods of using20 Nov 2025US 2025/0352513 A2Enveric Biosciences Canada Inc.
Most cited
By later US patents
- Photodecomposable bases and photoresist compositions470US 8,614,047 B2International Business Machines Corporation · 2013
- Bottom antireflective coating compositions55US 8,088,548 B2AZ Electronic Materials USA Corp. · 2012
- Organo-platinum complex38US 4,359,425 AShionogi & Co., Ltd. · 1982
- Method for production of ultra-fine gold particle-immobilized oxides30US 5,051,394 AAgency of Industrial Science and Technology · 1991
- Method for extracting tobacco alkaloids27US 5,119,835 AB.A.T. Cigarettenfabriken GmbH · 1992